PrECOG, LLC, today announced the publication of final results from the pivotal phase 3 PATINA study in the New England ...

Adding Ibrance to maintenance therapy extends progression-free survival by 15.2 months in HR-positive, HER2-positive ...

People with compromised liver function may be able to reduce their risk of liver cancer or slow its progression with a simple ...

Experts discuss the small but promising study.

Cleveland Clinic researchers have found that nearly two-thirds of patients with HER2-positive metastatic breast cancer did ...

Researchers have discovered how pancreatic cancer reprograms its surroundings to spread quickly and stealthily. By using a ...

Prostate cancer (PCa) is one of the most common malignant tumors among men worldwide. Following androgen deprivation therapy ...

A small subpopulation of highly plastic cancer cells has been found to be for cancer progression and treatment resistance.

Low-dose aspirin may limit cancer metastasis by inhibiting platelet activation and enhancing T-cell immunity, supporting biomarker guided use while balancing bleeding risk overall.

The study of cancer genomics has revealed that both inherited (germline) and acquired (somatic) genetic variations significantly influence cancer ...